The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats

Journal of Experimental Medicine

Volumn 188, Issue 5, 1998, Pages 877-886

  Zhou, By Ming ^a,h   Sayad, Alain ^a,c,i   Simmons, William A ^a,j   Jones, Richard C ^d   Maika, Shanna D ^b,k   Satumtira, Nimman ^a   Dorris, Martha L ^a   Gaskell, Simon J ^d   Bordoli, Robert S ^e   Sartor, R Balfour ^f   Slaughter, Clive A ^b   Richardson, James A ^c   Hammer, Robert E ^b   Taurog, Joel D ^a,g  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e MICROMASS UK LTD   (United Kingdom)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h BROOKLYN HOSPITAL CENTER   (United States)

ⁱ Abou Jaoude Hospital   (Lebanon)

^j Argonex Pharmaceuticals   (United States)

^k UNIVERSITY OF TEXAS AT AUSTIN   (United States)

more..

Author keywords

Antigenic peptide; Arthritis; Human histocompatibility leukocyte antigen B27; Mass spectrometry; Transgenic rat

Indexed keywords

HLA B27 ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTHRITIS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FEMALE; GENE TARGETING; HISTOPATHOLOGY; HLA SYSTEM; HYPOTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ARTHRITIS; BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE EXPRESSION REGULATION; HLA-B27 ANTIGEN; HUMANS; INFLUENZA A VIRUS; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; PEPTIDE FRAGMENTS; PREVALENCE; PROTEIN BINDING; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSGENES; VIRAL CORE PROTEINS;

EID: 3543113108     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.5.877     Document Type: Article

References (41)

1. López de Castro, J.A. 1998. The pathogenetic role of HLA-B27 in chronic arthritis. Curr. Opin. Immunol. 10:59-66.
2. Taurog, J.D. 1998. HLA-B27 subtypes, disease susceptibility, and peptide binding specificity. In The Spondylarthritides. A. Calin and J.D. Taurog, editors. Oxford University Press, Oxford, UK. 267-274.
3. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7: 601-632.
4. Lehner, P.J., and P. Cresswell. 1996. Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8:59-67.
5. Benjamin, R., and P. Parham. 1990. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today. 11: 137-142.
6. Burmester, G.R., A. Daser, T. Kamradt, A. Krause, N.A. Mitchison, J. Sieper, and N. Wolf. 1995. Immunology of reactive arthritides. Annu. Rev. Immunol. 13:229-250.
7. Huang, F., E. Hermann, J. Wang, X.K. Cheng, W.C. Tsai, J. Wen, J.G. Kuipers, H. Kellner, B. Ackermann, G. Roth, et al. 1996. A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences. Infect. Immun. 64:120-127.
8. Breban, M., R.E. Hammer, J.A. Richardson, and J.D. Taurog. 1993. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J. Exp. Med. 178:1606-1616.
9. Breban, M., J.L. Fernández-Sueiro, J.A. Richardson, R.R. Hadavand, S.D. Maika, R.E. Hammer, and J.D. Taurog. 1996. T cells but not thymic exposure to HLA-B27 are required for the inflammatory disease of HLA-B27 transgenic rats. J. Immunol. 156:794-803.
10. Simmons, W.A., L.Y.W. Leong, N. Satumtira, G.W. Butcher, J.C. Howard, J.A. Richardson, C.A. Slaughter, R.E. Hammer, and J.D. Taurog. 1996. Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease. J. Immunol. 156:1661-1667.
11. Khare, S.D., H.S. Luthra, and C.S. David. 1995. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking β2-microglobulin: a model of human spondyloarthropathies. J. Exp. Med. 182:1153-1158.
12. Taurog, J.D., R.E. Hammer, S.D. Maika, K.L. Sams, F.A.K. El-Zaatari, S.A. Stimpson, and J.H. Schwab. 1990. HLA-B27 transgenic mice as potential models of human disease. In Transgenic Mice and Mutants in MHC Research. I.K. Egorov and C.S. David, editors. Springer-Verlag, Berlin. 268-275.
13. Taurog, J.D., S.D. Maika, W.A. Simmons, M. Breban, and R.E. Hammer. 1993. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J. Immunol. 150:4168-4178.
14. Taurog, J.D., J.A. Richardson, J.T. Croft, W.A. Simmons, M. Zhou, J.L. Fernández-Sueiro, E. Balish, and R.E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359-2364.
15. Hammer, R.E., S.D. Maika, J.A. Richardson, J.-P. Tang, and J.D. Taurog. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2-m: an animal model of HLA-B27-associated human disorders. Cell. 63:1099-1112.
16. Simmons, W.A., J.D. Taurog, R.E. Hammer, and M. Breban. 1993. Sharing of an HLA-B27-restricted H-Y antigen by rat and mouse. Immunogenetics. 38:351-358.
17. Simmons, W.A., S.G. Summerfield, D.C. Roopenian, C.A. Slaughter, A.R. Zuberi, S.J. Gaskell, R.S. Bordoli, J. Hoyes, C.R. Moomaw, R.A. Colbert, et al. 1997. Novel HY peptide antigens presented by HLA-B27. J. Immunol. 159:2750-2759.
18. Anderson, K., P. Cresswell, M. Gammon, J. Hermes, A. Williamson, and H. Zweerink. 1991. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174:489-492.
19. Wold, W.S.M., and L.R. Gooding. 1989. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol. Biol. Med. 6:433-452.
20. Huet, S., D.F. Nixon, J.B. Rothbard, A. Townsend, S.A. Ellis, and A.J. McMichael. 1990. Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA 1327. Int. Immunol. 2:311-316.
21. a encoded antigens in T cell receptor Vβ8.1 chain transgenic mice. EMBO (Eur. Mol. Biol. Organ.) J. 8:719-727.
22. Colbert, R.A., S.L. Rowland-Jones, A.J. McMichael, and J.A. Frelinger. 1993. Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide. Proc. Natl. Acad. Sci. USA. 90:6879-6883.
23. Carreno, B.M., S. Koenig, J.E. Coligan, and W.E. Biddison. 1992. The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping. Mol. Immunol. 29:1131-1140.
24. Simmons, W.A., D.C. Roopenian, S.G. Summerfield, R.C. Jones, B. Galocha, G.J. Christianson, S.D. Maika, M. Zhou, S.J. Gaskell, R.S. Bordoli, et al. 1997. A new MHC locus that influences class I peptide presentation. Immunity. 7:641-651.
25. Rath, H.C., H.H. Herfarth, J.S. Ikeda, W.B. Grenther, T.E. Hamm, Jr., E. Balish, J.D. Taurog, R.E. Hammer, and R.B. Sartor. 1996. Normal luminal bacteria, especially bacteroides species, mediate chronic colonic, gastric, and systemic inflammation in HLA-B27/hβ2m transgenic rats. J. Clin. Invest. 98: 945-953.
26. Engelhard, V.H. 1994. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12: 181-207.
27. Rock, K.L. 1996. A new foreign policy - MHC class I molecules monitor the outside world. Immunol. Today. 17:131-137.
28. Mielants, H., and E.M. Veys. 1998. The bowel and spondylarthritis: a clinical approach. In The Spondylarthritides. A. Calin andJ.D. Taurog, editors. Oxford University Press, Oxford, UK. 129-158.
29. Taurog, J.D., N. Satumtira, J.A. Richardson, W.A. Simmons, and R.E. Hammer. 1996. Alleles of the inbred dark agouti (DA) rat strain are protective against inflammatory disease in HLA-B27 transgenic rats. Arthritis Rheum. 39:S121. (Abstr.)
30. Taurog, J.D., S.D. Maika, W.A. Simmons, J.A. Richardson, and R.E. Hammer. 1994. The inflammatory disease of HLA-B27 rats: evidence for the specificity of B27. Arthritis Rheum. 37:S223. (Abstr.)
31. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
32. Parham, F. 1996. Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis. Immunol. Rev. 54:137-154.
33. Gonzalez-Roces, S., M.F. Alvarez, S. Gonzalez, A. Dieye, H. Makni, D.G. Woodfield, L. Housan, V. Konenkov, M.C. Abbadi, N. Grunnet, et al. 1997. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens. 49:116-123.
34. D'Amato, M., M.T. Fiorillo, C. Carcassi, A. Mathieu, A. Zuccarelli, P.P. Bitti, R. Tosi, and R. Sorrentino. 1995. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 25:3199-3201.
35. Ren, E.C., W.H. Koh, D. Sim, M.L. Boey, G.B. Wee, and S.H. Chan. 1997. Possible protective role of HLA-B*2706 for ankylosing spondylitis. Tissue Antigens. 49:67-69.
36. Nasution, A.R., A. Mardjuadi, S. Kunmartini, N.G. Suryadhana, B. Setyohadi, D. Sudarsono, N.M. Lardy, and T.E.W. Feltkamp. 1997. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J. Rheumatol. 24:1111-1114.
37. Garcia, F., A. Marina, and J.A. Lopez de Castro. 1997. Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated with ankylosing spondylitis. Tissue Antigens. 49:215-221.
38. Fiorillo, M.T., L. Meadows, M. D'Amato, J. Shabanowitz, D.F. Hunt, E. Appella, and R. Sorrentino. 1997. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur. J. Immunol. 27:368-373.
39. Wucherpfennig, K.W., and J.L. Strominger. 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1597-1601.
40. Powis, S.J., L.L. Young, E. Joly, P.J. Barker, L. Richardson, R.P. Brandt, C.J. Melief, J.C. Howard, and G.W. Butcher. 1996. The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. Immunity. 4:159-165.
41. Biemann, K. 1988. Contributions of mass spectrometry to peptide and protein structure. Biomed. Environ. Mass Spectrom. 16:99-111.